The only notable update this month is on the status of Pradaxa. The FDA approved this medication as an anticoagulant for use with atrial fibrillation in October, 2010. We should hear any day now from the FAA that the status of Pradaxa is now in the “allowed for aviation use” category. You can check our medications database for the status of Pradaxa and over 400 other medications.
Effient was recently accepted for use. The FAA does include some restrictions, however, so here they are:
1. No certification for anyone age 75 or older; or
2. No history of TIA or any type of stroke; or
3. Taking more than the FDA-recommended dose [5-10 mg per day]
All situations that involve the use of Effient are case by case, so complete medical records, as always, will be required before the FAA will grant certification.
November 17, 2011